Drug intelligence / Profile preview

acridine orange

Development stage
Preclinical
Modality
Small Molecules
Administration
Intravenous, Intraperitoneal, Topical
01

Overview

**Acridine orange** is a synthetic, cell-permeable, nucleic acid-selective fluorescent cationic dye of the aminoacridine class[2][3][4]. It accumulates preferentially in acidic compartments such as lysosomes, binds nucleic acids (DNA and RNA), and upon excitation emits green or red fluorescence depending on the target[2][3][4]. Acridine orange acts as a DNA intercalator (binds via insertion between base pairs) and associates electrostatically with RNA[4]. It has recently been investigated for **anticancer mechanisms** that exploit its accumulation in acidic cellular compartments of tumors and its photodynamic or radiodynamic activation, which induces cytotoxicity preferentially in tumor cells[1][3][5]. AO affects mitochondrial activity and can induce cell death via mitotoxicity and lysosomal disruption. Its strong fluorescence has made it a widely used tool in fluorescence-guided surgery, imaging, and autophagy/cell cycle research[3][5].

Brand names
acridine orange
Other names
acridine orange baseN3,N3,N6,N6-Tetramethylacridine-3,6-diamineSolvent Orange 15c.i.46005beuchrysineCI 46005CI46005CI-46005C.I.46005:1waxolineorangeaoranzakridinova
02

Targets

DNA

Beyond the preview

Go deeper on acridine orange.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acridine orange.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call